Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.530

-0.120 (-4.53%)

At close: Mar 3, 2026, 4:00 PM EST

2.530

0.00 (0.00%)

Pre-market: Mar 4, 2026, 5:45 AM EST

Allogene Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	37.82	75.22	83.16	61.9	173.31	183.35
Short-Term Investments	214.38	217.26	365.54	455.42	283.99	644.56
Cash & Short-Term Investments	252.19	292.48	448.7	517.32	457.3	827.91
Cash Growth	-13.50%	-34.82%	-13.26%	13.12%	-44.76%	56.05%
Other Current Assets	8.53	10.91	10.42	11.5	14.02	17.22
Total Current Assets	260.72	303.39	459.12	528.82	471.32	845.13
Net Property, Plant & Equipment	116.83	131.26	163.18	196.43	181.02	160.14
Long-Term Investments	24.94	80.67	3.65	76.47	382.38	207.95
Other Long-Term Assets	37.28	33.39	16.9	19.86	16.11	14.62
Total Assets	439.77	548.71	642.84	821.58	1,051	1,228
Accounts Payable	3.7	5.39	5.9	13.89	10.26	10.39
Accrued Expenses	28.13	30.13	31.18	39.74	37.5	44.94
Unearned Revenue	-	-	-	0.1	0.16	38.99
Total Current Liabilities	31.83	35.52	37.08	53.73	47.91	94.32
Long-Term Leases	77.13	83.25	88.35	95.12	69.93	50.81
Other Long-Term Liabilities	15.48	7.76	5.18	5.85	7.79	3.08
Total Long-Term Liabilities	92.61	91.01	93.53	100.97	77.72	53.89
Total Liabilities	124.44	126.53	130.6	154.7	125.63	148.21
Common Stock	0.22	0.21	0.17	0	0.14	0.14
Additional Paid-in Capital	2,287	2,242	2,075	1,912	1,822	1,726
Accumulated Other Comprehensive Income	0.24	-0.09	-0.96	-9.93	-2.57	0.27
Retained Earnings	-1,972	-1,820	-1,562	-1,235	-894.55	-646.34
Shareholders' Equity	315.33	422.18	512.23	666.88	925.2	1,080
Total Liabilities & Equity	439.77	548.71	642.84	821.58	1,051	1,228
Total Debt	77.13	83.25	88.35	95.12	69.93	50.81
Net Cash (Debt)	175.06	209.23	360.35	422.2	387.37	777.1
Net Cash Growth	-16.33%	-41.94%	-14.65%	8.99%	-50.15%	62.17%
Net Cash Per Share	0.81	1.07	2.30	2.95	2.85	6.46
Book Value	315.33	422.18	512.23	666.88	925.2	1,080
Book Value Per Share	1.45	2.17	3.26	4.66	6.81	8.97
Tangible Book Value	315.33	422.18	512.23	666.88	925.2	1,080
Tangible Book Value Per Share	1.45	2.17	3.26	4.66	6.81	8.97

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q